Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
International Journal of Molecular Sciences|September 14, 2024
Hypertriglyceridemia Therapy: Past, Present and Future PerspectivesIleana Canfora, Sabata PiernoCells|August 26, 2022
Metabolic Pathways and Ion Channels Involved in Skeletal Muscle Atrophy: A Starting Point for Potential Therapeutic StrategiesIleana Canfora, Nancy Tarantino, Sabata PiernoCells|February 15, 2022
Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal MuscleNancy Tarantino, Ileana Canfora, Giulia Maria Camerino, et al.International Journal of Molecular Sciences|March 6, 2021
Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical EvidenceGiulia Maria Camerino, Nancy Tarantino, Ileana Canfora, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 25, 2024
Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse modelIleana Canfora, Concetta Altamura, Jean-Francois Desaphy, et al.International Journal of Molecular Sciences|January 21, 2023
Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and RiskSabata Pierno, Olimpia MusumeciJournal of Translational Medicine|July 26, 2015
Taurine: the appeal of a safe amino acid for skeletal muscle disordersAnnamaria De Luca, Sabata Pierno, Diana Conte CamerinoNeuromuscular Disorders : NMD|September 11, 2002
Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectivenessAnnamaria De Luca, Sabata Pierno, Antonella Liantonio, et al.Advances in Genetics|January 24, 2009
Therapeutic approaches to ion channel diseasesDiana Conte Camerino, Jean-François Desaphy, Domenico Tricarico, et al.Molecular Pharmacology|February 28, 2003
Different ability of clenbuterol and salbutamol to block sodium channels predicts their therapeutic use in muscle excitability disordersJean-François Desaphy, Sabata Pierno, Annamaria De Luca, et al.Pageof 6